The AI Driven Treatment Gap: A Glimpse into the Future of Rare Disease Care The startup world often prioritizes flashy tech over tangible impact.
However, Nome's recent partnership with the DAND Alliance offers a compelling exception.
By using artificial intelligence to help rare disease families develop custom treatments, Nome appears to be bridging the gap between cutting edge technology and compassionate care.